1. 2023 ICD-10-CM Index
›
2. 'L' Terms
›
3. Index Terms Starting With 'L' (Long-term)

Index Terms Starting With 'L' (Long-term)

• Long-term (current) (prophylactic) drug therapy (use of)

  • 5-fluorouracil Z79.631
    ICD-10-CM Diagnosis Code Z79.631

    Long term (current) use of antimetabolite agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of 5-fluorouracil
    • Long term (current) use of 6-mercaptopurine
    • Long term (current) use of cytarabine
    • Long term (current) use of methotrexate
  • 6-mercaptopurine Z79.631
    ICD-10-CM Diagnosis Code Z79.631

    Long term (current) use of antimetabolite agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of 5-fluorouracil
    • Long term (current) use of 6-mercaptopurine
    • Long term (current) use of cytarabine
    • Long term (current) use of methotrexate
  • adalimumab Z79.620
    ICD-10-CM Diagnosis Code Z79.620

    Long term (current) use of immunosuppressive biologic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of adalimumab
    • Long term (current) use of etanercept
    • Long term (current) use of infliximab
    • Long term (current) use of monoclonal antibodies
  • agents affecting estrogen receptors and estrogen levels NEC Z79.818
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • alkylating agent Z79.630
    ICD-10-CM Diagnosis Code Z79.630

    Long term (current) use of alkylating agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of chlorambucil
    • Long term (current) use of cisplatin
    • Long term (current) use of cyclophosphamide
  • anastrozole Z79.811
    (Arimidex)
    ICD-10-CM Diagnosis Code Z79.811

    Long term (current) use of aromatase inhibitors

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of anastrozole (Arimidex)
    • Long term (current) use of exemestane (Aromasin)
    • Long term (current) use of letrozole (Femara)
  • anti-inflammatory, non-steroidal Z79.1
    (NSAID)
    ICD-10-CM Diagnosis Code Z79.1

    Long term (current) use of non-steroidal anti-inflammatories (NSAID)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Type 2 Excludes

    • long term (current) use of aspirin (Z79.82)
  • antibiotics Z79.2
    ICD-10-CM Diagnosis Code Z79.2

    Long term (current) use of antibiotics

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • short-term use - omit code
  • anticoagulants Z79.01
    ICD-10-CM Diagnosis Code Z79.01

    Long term (current) use of anticoagulants

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • antidiabetic drugs, injectable, non-insulin Z79.85
    ICD-10-CM Diagnosis Code Z79.85

    Long-term (current) use of injectable non-insulin antidiabetic drugs

    2023 - New Code Billable/Specific Code POA Exempt

    Type 2 Excludes

    • long term (current) use of insulin (Z79.4)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
  • antimetabolite agent Z79.631
    ICD-10-CM Diagnosis Code Z79.631

    Long term (current) use of antimetabolite agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of 5-fluorouracil
    • Long term (current) use of 6-mercaptopurine
    • Long term (current) use of cytarabine
    • Long term (current) use of methotrexate
  • antiplatelet Z79.02
    ICD-10-CM Diagnosis Code Z79.02

    Long term (current) use of antithrombotics/antiplatelets

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • antithrombotics Z79.02
    ICD-10-CM Diagnosis Code Z79.02

    Long term (current) use of antithrombotics/antiplatelets

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • antitumor antibiotic Z79.632
    ICD-10-CM Diagnosis Code Z79.632

    Long term (current) use of antitumor antibiotic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of bleomycin
    • Long term (current) use of doxorubicin
    • Long term (current) use of mitomycin C
  • apremilast Z79.61
    ICD-10-CM Diagnosis Code Z79.61

    Long term (current) use of immunomodulator

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of apremilast
    • Long term (current) use of immunomodulatory imide drug
    • Long term (current) use of lenalidomide
    • Long term (current) use of pomalidomide
  • aromatase inhibitors Z79.811
    ICD-10-CM Diagnosis Code Z79.811

    Long term (current) use of aromatase inhibitors

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of anastrozole (Arimidex)
    • Long term (current) use of exemestane (Aromasin)
    • Long term (current) use of letrozole (Femara)
  • aspirin Z79.82
    ICD-10-CM Diagnosis Code Z79.82

    Long term (current) use of aspirin

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • azathioprine Z79.624
    ICD-10-CM Diagnosis Code Z79.624

    Long term (current) use of inhibitors of nucleotide synthesis

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of azathioprine
    • Long term (current) use omycophenolate
    • Long term (current) use of purine synthesis (IMDH) inhibitors
  • birth control pill or patch Z79.3
    ICD-10-CM Diagnosis Code Z79.3

    Long term (current) use of hormonal contraceptives

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of birth control pill or patch
  • bisphosphonates Z79.83
    ICD-10-CM Diagnosis Code Z79.83

    Long term (current) use of bisphosphonates

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • bleomycin Z79.632
    ICD-10-CM Diagnosis Code Z79.632

    Long term (current) use of antitumor antibiotic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of bleomycin
    • Long term (current) use of doxorubicin
    • Long term (current) use of mitomycin C
  • calcineurin inhibitor Z79.621
    ICD-10-CM Diagnosis Code Z79.621

    Long term (current) use of calcineurin inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of cyclosporine
    • Long term (current) use of tacrolimus
  • chlorambucil Z79.630
    ICD-10-CM Diagnosis Code Z79.630

    Long term (current) use of alkylating agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of chlorambucil
    • Long term (current) use of cisplatin
    • Long term (current) use of cyclophosphamide
  • cisplatin Z79.630
    ICD-10-CM Diagnosis Code Z79.630

    Long term (current) use of alkylating agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of chlorambucil
    • Long term (current) use of cisplatin
    • Long term (current) use of cyclophosphamide
  • contraceptive, oral Z79.3
    ICD-10-CM Diagnosis Code Z79.3

    Long term (current) use of hormonal contraceptives

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of birth control pill or patch
  • cyclophosphamide Z79.630
    ICD-10-CM Diagnosis Code Z79.630

    Long term (current) use of alkylating agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of chlorambucil
    • Long term (current) use of cisplatin
    • Long term (current) use of cyclophosphamide
  • cyclosporine Z79.621
    ICD-10-CM Diagnosis Code Z79.621

    Long term (current) use of calcineurin inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of cyclosporine
    • Long term (current) use of tacrolimus
  • cytarabine Z79.631
    ICD-10-CM Diagnosis Code Z79.631

    Long term (current) use of antimetabolite agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of 5-fluorouracil
    • Long term (current) use of 6-mercaptopurine
    • Long term (current) use of cytarabine
    • Long term (current) use of methotrexate
  • doxorubicin Z79.632
    ICD-10-CM Diagnosis Code Z79.632

    Long term (current) use of antitumor antibiotic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of bleomycin
    • Long term (current) use of doxorubicin
    • Long term (current) use of mitomycin C
  • drug, specified NEC Z79.899
    ICD-10-CM Diagnosis Code Z79.899

    Other long term (current) drug therapy

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • estrogen receptor downregulators Z79.818
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • etanercept Z79.620
    ICD-10-CM Diagnosis Code Z79.620

    Long term (current) use of immunosuppressive biologic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of adalimumab
    • Long term (current) use of etanercept
    • Long term (current) use of infliximab
    • Long term (current) use of monoclonal antibodies
  • etoposide Z79.634
    ICD-10-CM Diagnosis Code Z79.634

    Long term (current) use of topoisomerase inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of etoposide
    • Long term (current) use of irinotecan
    • Long term (current) use of topotecan
  • Evista Z79.810
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • exemestane Z79.811
    (Aromasin)
    ICD-10-CM Diagnosis Code Z79.811

    Long term (current) use of aromatase inhibitors

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of anastrozole (Arimidex)
    • Long term (current) use of exemestane (Aromasin)
    • Long term (current) use of letrozole (Femara)
  • Fareston Z79.810
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • fulvestrant Z79.818
    (Faslodex)
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • gonadotropin-releasing hormone Z79.818
    (GnRH)
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • goserelin acetate Z79.818
    (Zoladex)
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • hormone replacement Z79.890
    ICD-10-CM Diagnosis Code Z79.890

    Hormone replacement therapy

    2016 2017 2018 - Revised Code 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • hydroxyurea Z79.64
    ICD-10-CM Diagnosis Code Z79.64

    Long term (current) use of myelosuppressive agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of hydroxyurea
  • immunomodulators, unspecified Z79.60
    ICD-10-CM Diagnosis Code Z79.60

    Long term (current) use of unspecified immunomodulators and immunosuppressants

    2023 - New Code Billable/Specific Code POA Exempt
    • specified NEC Z79.69
      ICD-10-CM Diagnosis Code Z79.69

      Long term (current) use of other immunomodulators and immunosuppressants

      2023 - New Code Billable/Specific Code POA Exempt
  • immunomodulatory imide drug Z79.61
    ICD-10-CM Diagnosis Code Z79.61

    Long term (current) use of immunomodulator

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of apremilast
    • Long term (current) use of immunomodulatory imide drug
    • Long term (current) use of lenalidomide
    • Long term (current) use of pomalidomide
  • immunosuppressants, unspecified Z79.60
    ICD-10-CM Diagnosis Code Z79.60

    Long term (current) use of unspecified immunomodulators and immunosuppressants

    2023 - New Code Billable/Specific Code POA Exempt
    • specified NEC Z79.69
      ICD-10-CM Diagnosis Code Z79.69

      Long term (current) use of other immunomodulators and immunosuppressants

      2023 - New Code Billable/Specific Code POA Exempt
  • immunosuppressive biologic Z79.620
    ICD-10-CM Diagnosis Code Z79.620

    Long term (current) use of immunosuppressive biologic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of adalimumab
    • Long term (current) use of etanercept
    • Long term (current) use of infliximab
    • Long term (current) use of monoclonal antibodies
  • infliximab Z79.620
    ICD-10-CM Diagnosis Code Z79.620

    Long term (current) use of immunosuppressive biologic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of adalimumab
    • Long term (current) use of etanercept
    • Long term (current) use of infliximab
    • Long term (current) use of monoclonal antibodies
  • inhibitors of nucleotide synthesis Z79.624
    ICD-10-CM Diagnosis Code Z79.624

    Long term (current) use of inhibitors of nucleotide synthesis

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of azathioprine
    • Long term (current) use omycophenolate
    • Long term (current) use of purine synthesis (IMDH) inhibitors
  • insulin Z79.4
    ICD-10-CM Diagnosis Code Z79.4

    Long term (current) use of insulin

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Type 2 Excludes

    • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
    • long term (current) use of oral antidiabetic drugs (Z79.84)
    • long term (current) use of oral hypoglycemic drugs (Z79.84)
  • irinotecan Z79.634
    ICD-10-CM Diagnosis Code Z79.634

    Long term (current) use of topoisomerase inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of etoposide
    • Long term (current) use of irinotecan
    • Long term (current) use of topotecan
  • Janus kinase inhibitor Z79.622
    ICD-10-CM Diagnosis Code Z79.622

    Long term (current) use of Janus kinase inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of tofacitinib
  • lenalidomide Z79.61
    ICD-10-CM Diagnosis Code Z79.61

    Long term (current) use of immunomodulator

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of apremilast
    • Long term (current) use of immunomodulatory imide drug
    • Long term (current) use of lenalidomide
    • Long term (current) use of pomalidomide
  • letrozole Z79.811
    (Femara)
    ICD-10-CM Diagnosis Code Z79.811

    Long term (current) use of aromatase inhibitors

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of anastrozole (Arimidex)
    • Long term (current) use of exemestane (Aromasin)
    • Long term (current) use of letrozole (Femara)
  • leuprolide acetate Z79.818
    (leuprorelin) (Lupron)
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • mammalian target of rapamycin Z79.623
    (mTOR)
    ICD-10-CM Diagnosis Code Z79.623

    Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of sirolimus
  • megestrol acetate Z79.818
    (Megace)
    ICD-10-CM Diagnosis Code Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of estrogen receptor downregulators
    • Long term (current) use of fulvestrant (Faslodex)
    • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
    • Long term (current) use of goserelin acetate (Zoladex)
    • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
    • Long term (current) use of megestrol acetate (Megace)
  • methadone for pain management Z79.891
    ICD-10-CM Diagnosis Code Z79.891

    Long term (current) use of opiate analgesic

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of methadone for pain management

    Type 1 Excludes

    • methodone use NOS (F11.9-)
    • use of methodone for treatment of heroin addiction (F11.2-)
  • mitomycin C Z79.632
    ICD-10-CM Diagnosis Code Z79.632

    Long term (current) use of antitumor antibiotic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of bleomycin
    • Long term (current) use of doxorubicin
    • Long term (current) use of mitomycin C
  • mitotic inhibitor Z79.633
    ICD-10-CM Diagnosis Code Z79.633

    Long term (current) use of mitotic inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of paclitaxel
    • Long term (current) use of plant alkaloids
    • Long term (current) use of vinblastine
    • Long term (current) use of vincristine
  • monoclonal antibodies Z79.620
    ICD-10-CM Diagnosis Code Z79.620

    Long term (current) use of immunosuppressive biologic

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of adalimumab
    • Long term (current) use of etanercept
    • Long term (current) use of infliximab
    • Long term (current) use of monoclonal antibodies
  • myelosuppressive agent Z79.64
    ICD-10-CM Diagnosis Code Z79.64

    Long term (current) use of myelosuppressive agent

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of hydroxyurea
  • Nolvadex Z79.810
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • non-insulin antidiabetic drug, injectable Z79.899
    ICD-10-CM Diagnosis Code Z79.899

    Other long term (current) drug therapy

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • non-steroidal anti-inflammatories Z79.1
    (NSAID)
    ICD-10-CM Diagnosis Code Z79.1

    Long term (current) use of non-steroidal anti-inflammatories (NSAID)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Type 2 Excludes

    • long term (current) use of aspirin (Z79.82)
  • omycophenolate Z79.624
    ICD-10-CM Diagnosis Code Z79.624

    Long term (current) use of inhibitors of nucleotide synthesis

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of azathioprine
    • Long term (current) use omycophenolate
    • Long term (current) use of purine synthesis (IMDH) inhibitors
  • opiate analgesic Z79.891
    ICD-10-CM Diagnosis Code Z79.891

    Long term (current) use of opiate analgesic

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of methadone for pain management

    Type 1 Excludes

    • methodone use NOS (F11.9-)
    • use of methodone for treatment of heroin addiction (F11.2-)
  • oral
    • antidiabetic Z79.84
      ICD-10-CM Diagnosis Code Z79.84

      Long term (current) use of oral hypoglycemic drugs

      2017 - New Code 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

      Applicable To

      • Long term (current) use of oral antidiabetic drugs

      Type 2 Excludes

      • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
      • long term (current) use of insulin (Z79.4)
    • contraceptive Z79.3
      ICD-10-CM Diagnosis Code Z79.3

      Long term (current) use of hormonal contraceptives

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

      Applicable To

      • Long term (current) use of birth control pill or patch
    • hypoglycemic Z79.84
      ICD-10-CM Diagnosis Code Z79.84

      Long term (current) use of oral hypoglycemic drugs

      2017 - New Code 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

      Applicable To

      • Long term (current) use of oral antidiabetic drugs

      Type 2 Excludes

      • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
      • long term (current) use of insulin (Z79.4)
  • paclitaxel Z79.633
    ICD-10-CM Diagnosis Code Z79.633

    Long term (current) use of mitotic inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of paclitaxel
    • Long term (current) use of plant alkaloids
    • Long term (current) use of vinblastine
    • Long term (current) use of vincristine
  • plant alkaloids Z79.633
    ICD-10-CM Diagnosis Code Z79.633

    Long term (current) use of mitotic inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of paclitaxel
    • Long term (current) use of plant alkaloids
    • Long term (current) use of vinblastine
    • Long term (current) use of vincristine
  • pomalidomide Z79.61
    ICD-10-CM Diagnosis Code Z79.61

    Long term (current) use of immunomodulator

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of apremilast
    • Long term (current) use of immunomodulatory imide drug
    • Long term (current) use of lenalidomide
    • Long term (current) use of pomalidomide
  • purine synthesis Z79.624
    (IMDH)
    ICD-10-CM Diagnosis Code Z79.624

    Long term (current) use of inhibitors of nucleotide synthesis

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of azathioprine
    • Long term (current) use omycophenolate
    • Long term (current) use of purine synthesis (IMDH) inhibitors
  • raloxifene Z79.810
    (Evista)
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • selective estrogen receptor modulators Z79.810
    (SERMs)
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • sirolimus Z79.623
    ICD-10-CM Diagnosis Code Z79.623

    Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of sirolimus
  • steroids
    • inhaled Z79.51
      ICD-10-CM Diagnosis Code Z79.51

      Long term (current) use of inhaled steroids

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
    • systemic Z79.52
      ICD-10-CM Diagnosis Code Z79.52

      Long term (current) use of systemic steroids

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • tacrolimus Z79.621
    ICD-10-CM Diagnosis Code Z79.621

    Long term (current) use of calcineurin inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of cyclosporine
    • Long term (current) use of tacrolimus
  • tamoxifen Z79.810
    (Nolvadex)
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • tofacitinib Z79.622
    ICD-10-CM Diagnosis Code Z79.622

    Long term (current) use of Janus kinase inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of tofacitinib
  • topoisomerase inhibitor Z79.634
    ICD-10-CM Diagnosis Code Z79.634

    Long term (current) use of topoisomerase inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of etoposide
    • Long term (current) use of irinotecan
    • Long term (current) use of topotecan
  • topotecan Z79.634
    ICD-10-CM Diagnosis Code Z79.634

    Long term (current) use of topoisomerase inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of etoposide
    • Long term (current) use of irinotecan
    • Long term (current) use of topotecan
  • toremifene Z79.810
    (Fareston)
    ICD-10-CM Diagnosis Code Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of raloxifene (Evista)
    • Long term (current) use of tamoxifen (Nolvadex)
    • Long term (current) use of toremifene (Fareston)
  • vinblastine Z79.633
    ICD-10-CM Diagnosis Code Z79.633

    Long term (current) use of mitotic inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of paclitaxel
    • Long term (current) use of plant alkaloids
    • Long term (current) use of vinblastine
    • Long term (current) use of vincristine
  • vincristine Z79.633
    ICD-10-CM Diagnosis Code Z79.633

    Long term (current) use of mitotic inhibitor

    2023 - New Code Billable/Specific Code POA Exempt

    Applicable To

    • Long term (current) use of paclitaxel
    • Long term (current) use of plant alkaloids
    • Long term (current) use of vinblastine
    • Long term (current) use of vincristine